Efficacy, Tolerability and Handling of Daivobet® Gel in Patients With Psoriasis Vulgaris

• Status: Completed
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this observational study is to evaluate the efficacy, tolerability, quality of life and handling of Daivobet® Gel by both physician and patient in daily practise.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: LEO Pharma
• Collaborator: LEO Pharma GmbH, Neu-Isenburg, Germany
• Treatments: Betamethasone; Calcitriol

Criteria

Inclusion Criteria:

• Patients with light to moderate psoriasis vulgaris of trunk and extremities and treatment with Daivobet® Gel was planned anyway

Exclusion Criteria:

• Previous therapy with Daivobet® Gel

• Systemic therapy of psoriasis vulgaris

• Contraindications of Daivobet® Gel in the German package insert